Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cholecystolithiasis × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 NET 1 Head & Neck 1 Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 88 Pituitary Neoplasms 53 Neuroendocrine Tumors 47 Thyroid Cancer, Papillary 36 Pheochromocytoma 14 Obesity 14 Thyroid Neoplasms 13 Overweight 10 Paraganglioma 9 Carcinoma, Neuroendocrine 9 Adrenal Gland Neoplasms 9 Weight Loss 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Insulinoma 7 Gastrointestinal Neoplasms 7 Acquired Immunodeficiency Syndrome 7 Motor Activity 6 Brain Neoplasms 6 Stomach Neoplasms 5 Osteoporosis 5 Neoplasms 5 Neoplasm Metastasis 5 Meningioma 5 Insulin Resistance 5 Hyperaldosteronism 5 HIV Infections 5 Carcinoma, Medullary 5 Carcinoma, Hepatocellular 5 Carcinoid Tumor 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡